New research is freely available through Crystal Research Associates’ Research Library on MedeFile International Inc. (MDFI-OTCQB). Visit our library for the comprehensive 52-page PDF on MedeFile, a provider of Internet-enabled personal health records.

Today, we published a Quarterly Update on GenSpera, Inc., a biotechnology company developing targeted prodrugs for prostate and other cancers. The Company’s prodrug technologies were developed over 15 years at Johns Hopkins and other global research centers and funded by over $15 million in grants from the U.S. National Institutes of Health, the National Cancer Institute, and the U.S. Department of Defense, among others.

On Monday, May 3^rd we released a 16-page Quarterly Update on Applied DNA Sciences, Inc. (APDN-OTCBB), a company providing a range of patented DNA-based security and authentication solutions to protect products, brands, and intellectual property from theft, counterfeiting, fraud, and diversion.

After the close of business yesterday, we issued a 48-page Executive Informational Overview^® (EIO^®) on Document Capture Technologies, Inc. (DCMT-OTCBB). The full report can be accessed here.

This morning, we published a 48-page Executive Informational Overview (EIO) on WordLogic Corp., a development-stage technology company creating advanced methods of text and information entry for smartphones, computers, tablets, and other products with touchscreens, keypads, and keyboards. The report is available free of charge on our website, as well as through a number of other venues, such as Capital IQ, Reuters, and Yahoo! Finance. This EIO details WordLogic’s business strategies, novel technology platform, target markets, financial position, and competition, among other key factors relevant to evaluating an investment decision in the Company. 

This morning, we published a new Quarterly Update on Bioniche Life Sciences Inc. (BNC-TSX; BNC-ASX). Bioniche is a Canadian company providing innovative research, technologies, and therapeutics for human and animal health worldwide. Bioniche is structured in three global business units: (1) Bioniche Therapeutics (Human Health); (2) Bioniche Animal Health; and (3) Bioniche Food Safety. The following key areas, among many other of Bioniche’s business initiatives, are profiled in this newest update, which is available free of charge on our website.

After market close today, Crystal Research published a business update on Unilife Corp. (UNIS-NASDAQ). Beyond covering Unilife’s recent significant news and progress under its Industrialization Agreement with sanofi-aventis SA (SNY-NYSE), the update also includes an early look at Unilife’s financials for the second quarter of FY 2011, ended December 31, 2010. This data comes from Unilife’s Appendix 4C for the three and six months ended December 31, 2010, filed on January 31, 2011, with the Australian Securities Exchange (ASX).

We at Crystal are looking forward to an exciting week as we begin releasing new research in our revamped Coverage Library. This morning, we published a business update on innovative biopharmaceutical company, Peregrine Pharmaceuticals, Inc. (PPHM-NASDAQ).

Today we issued an updated, 44-page Executive Informational Overview® (EIO®) on Laep Investments Ltd. Laep’s Brazilian depositary receipts (BDRs) are traded on the São Paulo Stock Exchange (Bovespa) under the ticker “MILK11.” As well, the Company is listed on the Euro MTF market of the Luxembourg Stock Exchange.

Today we issued an updated, 44-page  Executive Informational Overview® (EIO®) on BELLUS Health Inc. (BLU-TSX). BELLUS, up more than 100% this morning after announcing the start of a Phase III trial for KIACTA yesterday, is a global health company focused on the research and development of innovative health solutions for critical, unmet medical needs. The Company’s pharmaceutical pipeline targets disorders for which there are no known cures.

After the close of business today, we released a new report on Authentidate Holding Corp. (ADAT-NASDAQ). We first initiated coverage on Authentidate in March 2009 and have watched the company expand greatly since then. Its flagship product is Inscrybe^® Healthcare, which provides a means for healthcare organizations and other enterprises to increase revenues, improve productivity, enhance patient care, and reduce costs by eliminating paper and manual work steps while enhancing regulatory compliance. During the past year, Authentidate has announced 11 new projects for Inscrybe^® Healthcare, which include sales to home medical equipment companies, home healthcare service agencies, and respiratory products and service institutions.

After the close of the market today, we published an updated Executive Informational Overview on Applied DNA Sciences, Inc. (APDN-OTC.BB). Follow the jump for a brief overview of Applied DNA or visit our website at www.crystalra.com to access the full 68-page report at no charge. As well, join our mailing list to be notified of new future report releases.

This morning, we at Crystal Research published a new Executive Informational Overview (go here to find out more about what is in an EIO) on Radient Pharmaceuticals Corp. (RPC-NYSE Amex). Read a brief overview of Radient below or visit our website at www.crystalra.com to access the full 64-page report at no charge.